4Basebio

4Basebio Goodwill

Goodwill of 4Basebio (4BB.L) as of Oct 19, 2026.

Goodwill

-GBP

Last updated:

Goodwill of 4Basebio is 2026 - GBP. Goodwill of 4Basebio was 2025 - GBP. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

4Basebio Stock analysis

What does 4Basebio do? 4Basebio PLC, based in Cambridge, UK, operates in the Health Care sector within the Biotechnology industry. The company develops advanced therapy medicinal products using synthetic DNA and non-viral, cell-targeting nucleic acid delivery platforms. It focuses on therapeutic DNA for cell and gene therapies, DNA vaccines, and provides solutions for safe and effective delivery of these products. 4Basebio manufactures application-specific synthetic DNA for research, therapeutic, and pharmacological use, and develops non-viral vectors for efficient payload delivery. Key applications include AAV and Lentivirus vectors, mRNA vaccines, genome editing, and DNA vaccines. 4Basebio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 4Basebio stock

On Eulerpool you can find the complete historical development of Goodwill 4Basebio since 2006 – with annual values, charts, and detailed analysis.

Goodwill is the premium paid above fair market value in an acquisition. It represents intangible value such as brand recognition, customer relationships, and intellectual property.

Goodwill's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill's 4Basebio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — 4Basebio

All Key Metrics — 4Basebio